STAAR Surgical Company

NASDAQ:STAA

Medical - Instruments & Supplies

Healthcare
$25.35 -1.37%

-$0.40 today

Market cap
$1.27B
Beta
1.23
P/E (TTM)
-68.3
EPS (TTM)
-$0.42
52W Low $15.59High $35.87

Volume 0.45M

Average 1.07M

STAA EPS (Diluted)

Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.

STAAR Surgical CompanyNASDAQ: STAA

EPS (Diluted) · Q1 FY2026 · quarter ended Apr 2026

EPS (Diluted) turns positive

Q1 FY2026 EPS (Diluted) was $0.1, compared with -$1.1 a year earlier. Trailing-twelve-month EPS (Diluted) was -$0.42.

Context

  • EPS (Diluted) increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether EPS (Diluted) reaches the consensus estimate from 5 analysts of $0.35 (+121.4%) for the fiscal year ending Jan 2027, a step up from the -295.1% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterApr 2026
$0.1+127.8% QoQ
Last fiscal yearJan 2026
-$1.62-295.1% YoY
LTMApr 2026
-$0.42+70.8% YoY
EPS (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+109.1%+165.1%+56.0 pp
1 year-295.1%+121.4%+416.5 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Diluted) history

USD · from the income statement

Latest · FY2025
(1.62) USD
Year-over-year change
-295.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Diluted) vs competitors

How STAA compares with its peers on the latest reported figures

  • STAA's LTM Apr 2026 EPS (Diluted) of -$0.42 is the 3rd highest of the 5 companies compared; the peer median is $0.44.
  • Its year-over-year change of +70.8% is the highest of 5, against a peer median of +1.6%.
STAA Competitors Peer median
EPS (Diluted) for STAA and competitors
Company Period LTM YoY 3-year CAGR
COOThe Cooper Companies, Inc.LTM Jul 2026$2.93 +44.3%-1.2%
ALCAlcon Inc.LTM Sep 2026$1.36 -35.2%+42.8%
STAASTAAR Surgical CompanyLTM Apr 2026-$0.42 +70.8%—
BLCOBausch + Lomb CorporationLTM Jun 2026-$0.48 +38.5%—
RXSTRxSight, Inc.LTM Mar 2026-$1.13 -68.7%—
Peer median (excluding STAA) $0.44+1.6%+20.8%

Competitors are the stored peer set for STAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Revenue230.47M284.39M322.42M313.9M239.44M
Cost of Revenue51.84M61.01M69.76M74.32M57.02M
Gross Profit178.64M223.38M252.65M239.58M182.42M
Gross Margin77.5%78.5%78.4%76.3%76.2%
Research & Development33.86M35.98M44.4M53.97M40.06M
Selling, General & Admin111.44M143.6M180.15M198.22M188.31M
Operating Expenses145.3M179.58M224.55M252.19M228.37M
Depreciation & Amortization3.64M4.51M5.12M6.89M8.73M
EBITDA34.98M50.06M38.82M(2.16M)(73.54M)
EBITDA Margin15.2%17.6%12.0%-0.7%-30.7%
Operating Income33.34M43.8M28.1M(12.61M)(45.95M)
Operating Margin14.5%15.4%8.7%-4.0%-19.2%
Interest Income—2.45M6.99M5.91M4.59M
Interest Expense38K0000
Other Income / Expenses(2.04M)1.75M5.6M3.56M(36.32M)
Income Before Tax31.3M45.55M33.7M(9.05M)(82.26M)
Pre-Tax Margin13.6%16.0%10.5%-2.9%-34.4%
Income Tax Expense3.79M5.89M12.35M11.16M(1.82M)
Net Income27.51M39.67M21.35M(20.21M)(80.45M)
Net Margin11.9%13.9%6.6%-6.4%-33.6%
EPS (Basic)0.520.830.44(0.41)(1.62)
EPS (Diluted)0.500.800.43(0.41)(1.62)
Weighted Avg Shares47.21M47.99M48.52M49.13M49.57M
Weighted Avg Shares (Diluted)49.46M49.38M49.43M49.13M49.57M

STAAR Surgical Company

NASDAQ:STAA

Intrinsic Alpha fair value

Locked

Current Price

$25.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.